Source: United-Guardian, Inc.
United-Guardian Reports Record Sales & Earnings
HAUPPAUGE, N.Y., March 24, 2014 (GLOBE NEWSWIRE) -- United-Guardian, Inc., (Nasdaq:UG) announced today that both earnings and sales set new company records in FY-2013. Earnings for the year were $5.9 million ($1.28 per share) on sales of $15.4 million, compared with earnings of $4.8 million ($1.05 per share) on sales of $13.8 million in 2012. This represents a 22% increase in earnings, and a 12% increase in sales, compared with 2012.
Ken Globus, President of United-Guardian, stated, "The increase in sales and earnings in 2013 was primarily the result of a significant increase in sales of our cosmetic ingredients, primarily our extensive Lubrajel™ line of water-based moisturizers and lubricants. Sales of those products increased by 21% in 2013, with sales in China alone increasing by over 40% compared with 2012. Attaining these record levels of sales and earnings was especially satisfying because we were able to do so despite having no sales of our most important pharmaceutical product, Renacidin™ Irrigation, until the last two months of the year, due to supply problems. Those problems have now been resolved, and we expect to have full product availability this year. As a result of the renewed sales of Renacidin, along with our planned introduction of some new personal care products and our continuing efforts to expand the sales of our existing personal care products, we are looking forward to another strong year in 2014."
United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, pharmaceuticals, and specialty industrial products.
NOTE: This press release contains both historical and "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company's expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the "safe harbor" provisions of that Act. Such statements are subject to a variety of factors that could cause Registrant's actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company's business please refer to the company's reports and filings with the Securities and Exchange Commission.
| RESULTS FOR THE YEARS ENDED | ||
| DECEMBER 31, 2013 AND DECEMBER 31, 2012 | ||
| INCOME STATEMENT DATA | ||
| Years ended December 31, | ||
| 2013 | 2012 | |
| Net sales | $ 15,416,893 | $ 13,825,764 |
| Costs and expenses: | ||
| Cost of sales | 5,610,813 | 5,218,959 |
| Operating expenses | 2,504,526 | 2,508,334 |
| Total costs and expenses | 8,115,339 | 7,727,293 |
| Income from operations | 7,301,554 | 6,098,471 |
| Other income (expense): | ||
| Investment income | 259,747 | 325,017 |
| (Loss) on sale of assets | --- | (14,861) |
| Income from damage settlement | 1,070,561 | 518,050 |
| Total other income, net | 1,330,308 | 828,206 |
| Income from operations before income taxes | 8,631,862 | 6,926,677 |
| Provision for income taxes | 2,728,553 | 2,095,897 |
| Net income | $ 5,903,309 | $ 4,830,780 |
| Earnings per common share (basic and diluted) | $ 1.28 | $ 1.05 |
| Weighted average shares (basic and diluted) | 4,596,439 | 4,596,439 |
| BALANCE SHEET DATA | ||
| December 31, | ||
| 2013 | 2012 | |
| Current assets | $ 14,307,218 | $ 12,623,403 |
| Property, plant, and equipment (net of accumulated depreciation) | 1,334,501 | 1,235,863 |
| Other asset | 9,147 | --- |
| Total assets | $ 15,650,866 | $ 13,859,266 |
| Current liabilities | $ 1,245,352 | $ 827,508 |
| Deferred income taxes | 169,587 | 193,740 |
| Total Liabilities | 1,414,939 | 1,021,248 |
| Stockholders' equity | 14,235,927 | 12,838,018 |
| Total liabilities and stockholders' equity | $ 15,650,866 | $ 13,859,266 |